Tolerance of interferon-alpha therapy in children with chronic hepatitis B

Journal of Paediatrics and Child Health

Volumn 40, Issue 5-6, 2004, Pages 265-269

  Liberek, A ^a   Luczak G ^a   Korzon, M ^a   Szlagatys Sidorkiewicz, A ^a   Bako, W ^a   Gora Gcbka M ^a   Rytlewska, M ^a   Sikorska Wisniewska G ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Children; Chronic hepatitis B; Interferon ; Side effects

Indexed keywords

ALANINE AMINOTRANSFERASE; AUTOANTIBODY; HEMOGLOBIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; RECOMBINANT ALPHA INTERFERON;

ABDOMINAL PAIN; ADOLESCENT; ANTIBODY TITER; ARTHRALGIA; CHILD; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DROWSINESS; DRUG MEGADOSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; EDEMA; FATIGUE; FEBRILE CONVULSION; FEMALE; FEVER; FLU LIKE SYNDROME; HAIR LOSS; HEADACHE; HEPATITIS B; HUMAN; HUMAN TISSUE; INJECTION PAIN; INTERVIEW; IRRITABILITY; LABORATORY TEST; LEUKOCYTE COUNT; LIVER FIBROSIS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALAISE; MALE; PARENT; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE; THROMBOCYTE COUNT; THYROID FUNCTION;

ADOLESCENT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; APPETITE; BLOOD PLATELETS; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER; HEADACHE; HEPATITIS B, CHRONIC; HUMANS; INFANT; INTERFERON-ALPHA; LEUKOCYTES; MALE; PROSPECTIVE STUDIES; STATISTICS; TIME FACTORS;

EID: 3042522793     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2004.00361.x     Document Type: Review

References (31)

1. Louis-Jacques O. Olson AD. Cost-benefit analysis of interferon therapy in children with chronic active hepatitis B. J. Pediatr. Gastroenterol. Nutr. 1997; 24: 25-32.
2. Socha J, Pawowska J, Woynarowski M et al. Results of alpha-interferon treatment in children with chronic viral hepatitis type B. Ped. Pol. 1992: 1-2 (Suppl.): 69-74 (in Polish with English abstract).
3. Shapiro CN. Epidemiology of hepatitis B. Pediatr. Infect. Dis. J. 1993; 12: 443.
4. Bortolotti F, Calzia R, Cadrobbi P et al. Liver cirrhosis associated with chronic hepatitis B virus infection in childhood. J. Pediatr. 1986; 108: 224-7.
5. Ruiz Moreno M. Chronic hepatitis B in children: Natural history and treatment. J. Hepatol. 1993; 17 (Suppl. 3): 64-6.
6. Torre D, Tambini R. Interferon-α therapy for chronic hepatitis B in children: a meta-analysis. Clin. Infect. Dis. 1996; 23: 131-7.
7. Perrillo RP. The management of chronic hepatitis B. Am. J. Med. 1994; 96: 34-9.
8. Woynarowski M, Socha J. Results of interferon alfa therapy in children with chronic viral hepatitis type B. Experiences of Polish centres 1990-97. Ped. Pol. 1998; 10: 1031-41 (in Polish with English abstract).
9. Sokal EM, Kelly D, Mizierski J et al. An international double-blind placebo-controlled trial of lamivudine in 286 children with chronic hepatitis B. J. Hepatol. 2001; 34 (Suppl. 1): 23.
10. Di Bisceglie AM, Fong TL, Fried MW et al. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B. Am. J. Gastroenterol. 1993; 88: 1887-92.
11. Lai CL, Lok AS. Lin HJ, Wu PC, Yeoh EK, Yeung CY. Placebo-controlled trial of recombinant alpha 2-interferon in Chinese HBsAg-carrier children. Lancet 1987; 2: 877-80.
12. Barbera C, Bortolotti F, Crivellaro C. Recombinant interferon-α2a hastens the rate of HBeAg clearance in children with chronic hepatitis B. Hepatology 1994; 20: 287-90.
13. Sokal EM, Conjeevaram H, Roberts EA et al. Interferon alfa for treatment of pediatric chronic hepatitis B: A randomized controlled multicenter trial. Hepatology 1997; 26: 427A.
14. Jonas MM. Interferon-α for viral hepatitis. J. Pediatr. Gastroenterol Nutr. 1996; 23: 93-106.
15. Schalm SW. Treatment of chronic hepatitis B. Neth. J. Med. 1994; 44: 103-9.
16. International Working Party. Terminology of chronic hepatitis. Am. J. Gastroenterol 1995; 90: 181.
17. Jara P, Bortolotti F. Interferon-α treatment of chronic hepatitis B in childhood: a consensus advice based on experience in European children. J. Pediatr. Gastroenterol Nutr. 1999; 29: 163-70.
18. Ruiz-Moreno M, Camps T. Jimenez J et al. Factors predictive of response to interferon therapy in children with chronic hepatitis B. J. Hepatol. 1995; 22: 540-4.
19. Schalm SW, Heathcote J, Cianciara J et al. Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial. Gut 2000; 46: 562-8.
20. Jonas MM, Kelley DA, Mizerski J et al. Clinical trial of lamivudine in children with chronic hepatitis B. N. Engl. J. Med. 2002; 346: 1706-13.
21. Ruiz Moreno M, Rua MJ, Molina J. Prospective, randomized trial of interferon-alpha in children with chronic hepatitis B. Hepatology 1991; 13: 1035-9.
22. Ruiz Moreno M. Interferon treatment in children with chronic hepatitis B. J. Hepatol. 1995; 22 (Suppl. 1): 49-51.
23. Shakil AO, Di Bisceglie AM. Hoofnagle JH. Seizures during alpha interferon therapy. J. Hepatol. 1996; 24: 48-51.
24. Renault PF, Hoofnagle JH. Park Y et al. Psychiatric complications of long-term interferon alfa therapy. Arch. Intern. Med. 1987; 147: 1577-80.
25. Sata M, Yano Y, Yoshiyama Y et al. Mechanisms of thrombocytopenia induced by interferon therapy for chronic hepatitis B. J. Gastroenterol. 1997; 32: 206-10.
26. Iorio R, Pensati P, Botta S et al. Side-effects of alpha-interferon therapy and impact on health-related quality of life in children with chronic viral hepatitis. Pediatr. Infect. Dis. J. 1997; 16: 984-90.
27. Hoofnagle JH, Di Bisceglie AM. Waggoner JG, Park Y. Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B. Gastroenterology 1993; 104: 1116-21.
28. Kowalik-Mikoajewska B, Ładyżyṅska E, Łoch T, Woynarowski M. Results of interferon treatment of chronic viral hepatitis B in children. Pol. Merk. Lek. 1997; 17: 241-4 (in Polish with English abstract).
29. Czaja AJ. Extrahepatic immunologic features of chronic viral hepatitis. Dig. Dis. 1997; 15: 125-44.
30. di Cesare E, Previti M. Russo F et al. Interferon-alpha therapy may induce insulin autoantibody development in patients with chronic viral hepatitis. Dig. Dis. Sci. 1996; 41: 1672-7.
31. Deutsch M, Dourakis S, Manesis EK et al. Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy. Hepatology 1997; 26: 206-10.